Literature DB >> 23512291

Telomerase activity in human brain tumors: astrocytoma and meningioma.

Majid Kheirollahi1, Masoud Mehrazin, Naser Kamalian, Javad Mohammadi-asl, Parvin Mehdipour.   

Abstract

Somatic cells do not have telomerase activity but immortalized cell lines and more than 85 % of the cancer cells show telomerase activation to prevent the telomere from progressive shortening. The activation of this enzyme has been found in a variety of human tumors and tumor-derived cell lines, but only few studies on telomerase activity in human brain tumors have been reported. Here, we evaluated telomerase activity in different grades of human astrocytoma and meningioma brain tumors. In this study, assay for telomerase activity performed on 50 eligible cases consisted of 26 meningioma, 24 astrocytoma according to the standard protocols. In the brain tissues, telomerase activity was positive in 39 (65 %) of 50 patients. One sample t test showed that the telomerase activity in meningioma and astrocytoma tumors was significantly positive entirely (P < 0.001). Also, grade I of meningioma and low grades of astrocytoma (grades I and II) significantly showed telomerase activity. According to our results, we suggest that activation of telomerase is an event that starts mostly at low grades of brain including meningioma and astrocytoma tumors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23512291     DOI: 10.1007/s10571-013-9923-x

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  29 in total

1.  Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.

Authors:  M L Falchetti; R Pallini; L M Larocca; R Verna; E D'Ambrosio
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Telomere maintenance by recombination in human cells.

Authors:  M A Dunham; A A Neumann; C L Fasching; R R Reddel
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

Review 3.  Telomeres and human disease: ageing, cancer and beyond.

Authors:  Maria A Blasco
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

Review 4.  Telomerase in brain tumors.

Authors:  M L Falchetti; L M Larocca; R Pallini
Journal:  Childs Nerv Syst       Date:  2002-02-23       Impact factor: 1.475

5.  Alterations of telomere length in human brain tumors.

Authors:  Majid Kheirollahi; Masoud Mehrazin; Naser Kamalian; Parvin Mehdipour
Journal:  Med Oncol       Date:  2010-04-07       Impact factor: 3.064

6.  Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.

Authors:  E Cabuy; L de Ridder
Journal:  Virchows Arch       Date:  2001-08       Impact factor: 4.064

7.  The significant role of telomerase activity in human brain tumors.

Authors:  K Nakatani; N Yoshimi; H Mori; S Yoshimura; H Sakai; J Shinoda; N Sakai
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

8.  Telomere length and telomerase activity in extra-abdominal desmoid tumors.

Authors:  Toshihiro Matsuo; Eiso Hiyama; Takashi Sugita; Shoji Shimose; Tadahiko Kubo; Yu Mochizuki; Nobuo Adachi; Mitsuo Ochi
Journal:  Anticancer Res       Date:  2007 Jan-Feb       Impact factor: 2.480

9.  Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.

Authors:  Cristina Garcia-Aranda; Carmen de Juan; Antonio Diaz-Lopez; Andres Sanchez-Pernaute; Antonio-Jose Torres; Eduardo Diaz-Rubio; Jose-Luis Balibrea; Manuel Benito; Pilar Iniesta
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

Review 10.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

View more
  8 in total

1.  Comprehensive analysis of Iranian reports of pediatric central nervous system tumors.

Authors:  Narjes Mehrvar; Azim Mehrvar; Mohammad Esmaeil Akbari; Ibrahim Qaddoumi
Journal:  Childs Nerv Syst       Date:  2017-05-29       Impact factor: 1.475

Review 2.  Vaccination strategies for neuro-oncology.

Authors:  John H Sampson; Duane A Mitchell
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

3.  TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.

Authors:  Sabine Spiegl-Kreinecker; Daniela Lötsch; Katharina Neumayer; Lucia Kastler; Johannes Gojo; Christine Pirker; Josef Pichler; Serge Weis; Rajiv Kumar; Gerald Webersinke; Andreas Gruber; Walter Berger
Journal:  Neuro Oncol       Date:  2018-11-12       Impact factor: 12.300

4.  Oncolytic adenoviruses: A thorny path to glioma cure.

Authors:  I V Ulasov; A V Borovjagin; B A Schroeder; A Y Baryshnikov
Journal:  Genes Dis       Date:  2014-12

Review 5.  Brain tumors: Special characters for research and banking.

Authors:  Majid Kheirollahi; Sepideh Dashti; Zahra Khalaj; Fatemeh Nazemroaia; Parvin Mahzouni
Journal:  Adv Biomed Res       Date:  2015-01-06

Review 6.  The evolving role of radiosurgery in the management of radiation-induced meningiomas: a review of current advances and future directions.

Authors:  Alireza Mansouri; Jetan Badhiwala; Sheila Mansouri; Gelareh Zadeh
Journal:  Biomed Res Int       Date:  2014-07-17       Impact factor: 3.411

7.  Assessment Effects of Resveratrol on Human Telomerase Reverse Transcriptase Messenger Ribonucleic Acid Transcript in Human Glioblastoma.

Authors:  Azin Mirzazadeh; Majid Kheirollahi; Ehsan Farashahi; Fatemeh Sadeghian-Nodoushan; Mohammad Hasan Sheikhha; Behrouz Aflatoonian
Journal:  Adv Biomed Res       Date:  2017-06-27

Review 8.  The Emerging Roles for Telomerase in the Central Nervous System.

Authors:  Meng-Ying Liu; Ashley Nemes; Qi-Gang Zhou
Journal:  Front Mol Neurosci       Date:  2018-05-16       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.